BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25188497)

  • 1. Local and systemic RAGE axis changes in pulmonary hypertension: CTEPH and iPAH.
    Moser B; Megerle A; Bekos C; Janik S; Szerafin T; Birner P; Schiefer AI; Mildner M; Lang I; Skoro-Sajer N; Sadushi-Kolici R; Taghavi S; Klepetko W; Ankersmit HJ
    PLoS One; 2014; 9(9):e106440. PubMed ID: 25188497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The receptor for advanced glycation endproducts and its ligands in patients with myasthenia gravis.
    Moser B; Bekos C; Zimprich F; Nickl S; Klepetko W; Ankersmit J
    Biochem Biophys Res Commun; 2012 Mar; 420(1):96-101. PubMed ID: 22405771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
    Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
    J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension.
    Diekmann F; Chouvarine P; Sallmon H; Meyer-Kobbe L; Kieslich M; Plouffe BD; Murthy SK; Lichtinghagen R; Legchenko E; Hansmann G
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased time constant of the pulmonary circulation in chronic thromboembolic pulmonary hypertension.
    MacKenzie Ross RV; Toshner MR; Soon E; Naeije R; Pepke-Zaba J
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(2):H259-64. PubMed ID: 23686712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation.
    Romero R; Espinoza J; Hassan S; Gotsch F; Kusanovic JP; Avila C; Erez O; Edwin S; Schmidt AM
    J Perinat Med; 2008; 36(5):388-98. PubMed ID: 18593373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry].
    Chazova IE; Valieva ZS; Nakonechnikov SN; Taran IN; Martynyuk TV
    Ter Arkh; 2019 Sep; 91(9):77-87. PubMed ID: 32598818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peripheral small airway dysfunction differences between idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension].
    An QY; Jiang R; Wang L; Zhao QH; Gong SG; He J; Luo CJ; Liu MQ; Qiu HL; Guo J; Liu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Dec; 41(12):934-941. PubMed ID: 30522190
    [No Abstract]   [Full Text] [Related]  

  • 9. Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertension.
    Suntharalingam J; Machado RD; Sharples LD; Toshner MR; Sheares KK; Hughes RJ; Jenkins DP; Trembath RC; Morrell NW; Pepke-Zaba J
    Thorax; 2007 Jul; 62(7):617-22. PubMed ID: 17287300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [End tidal PCO(2) for evaluation of severity of disease in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension].
    Shi X; Yang GL; Chen Y; Guo J; Yang WL; Yuan P; Gong SG; Jiang R; Zhao QH; Wang L; He J; Chen TX; Liu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Jan; 40(1):34-39. PubMed ID: 28100360
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating soluble receptor for advanced glycation end-product levels are decreased in patients with calcific aortic valve stenosis.
    Basta G; Corciu AI; Vianello A; Del Turco S; Foffa I; Navarra T; Chiappino D; Berti S; Mazzone A
    Atherosclerosis; 2010 Jun; 210(2):614-8. PubMed ID: 20074734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Roles of S100A4 and the EGF/EGFR Signaling Axis in Pulmonary Hypertension with Right Ventricular Hypertrophy.
    Laggner M; Hacker P; Oberndorfer F; Bauer J; Raunegger T; Gerges C; Szerafin T; Thanner J; Lang I; Skoro-Sajer N; Ankersmit HJ; Moser B
    Biology (Basel); 2022 Jan; 11(1):. PubMed ID: 35053115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Levels of Receptor for Advanced Glycation End-Products and High-Mobility Group Box 1 in Patients With Pulmonary Hypertension.
    Suzuki S; Nakazato K; Sugimoto K; Yoshihisa A; Yamaki T; Kunii H; Suzuki H; Saitoh S; Takeishi Y
    Int Heart J; 2016; 57(2):234-40. PubMed ID: 26973260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study.
    Jabaudon M; Blondonnet R; Roszyk L; Pereira B; Guérin R; Perbet S; Cayot S; Bouvier D; Blanchon L; Sapin V; Constantin JM
    PLoS One; 2015; 10(8):e0135857. PubMed ID: 26274928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis.
    Atzeni IM; Al-Adwi Y; Doornbos-van der Meer B; Roozendaal C; Stel A; van Goor H; Gan CT; Dickinson M; Timens W; Smit AJ; Westra J; Mulder DJ
    Front Immunol; 2023; 14():1189257. PubMed ID: 37409127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Olsson KM; Olle S; Fuge J; Welte T; Hoeper MM; Lerch C; Maegel L; Haller H; Jonigk D; Schiffer L
    Respir Res; 2016 Feb; 17():21. PubMed ID: 26927848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
    Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
    Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBD.
    Meijer B; Hoskin T; Ashcroft A; Burgess L; Keenan JI; Falvey J; Gearry RB; Day AS
    J Crohns Colitis; 2014 Jun; 8(6):513-20. PubMed ID: 24291021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble form of receptor for advanced glycation end-products (sRAGE): do sRAGE ligands or anti-sRAGE auto-antibodies interfere with sRAGE quantification?
    Lorenzi R; Grossin N; Lambert M; Daroux M; Adjoutah Z; Flahaut C; Jacolot P; Tessier FJ; Lefranc D; Desremaux P; Dubucquoi S; Boulanger E
    Ann Clin Biochem; 2014 Mar; 51(Pt 2):248-57. PubMed ID: 23982266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the receptor for advanced glycation end products in liver transplantation.
    Navarra T; De Simone P; Del Turco S; Filipponi F; Basta G
    Ann Hepatol; 2015; 14(2):190-7. PubMed ID: 25671828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.